These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34575091)

  • 1. Potential Salivary Markers for Differential Diagnosis of Crohn's Disease and Ulcerative Colitis.
    Nijakowski K; Rutkowski R; Eder P; Simon M; Korybalska K; Witowski J; Surdacka A
    Life (Basel); 2021 Sep; 11(9):. PubMed ID: 34575091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease.
    Nijakowski K; Rutkowski R; Eder P; Korybalska K; Witowski J; Surdacka A
    Life (Basel); 2021 Dec; 11(12):. PubMed ID: 34947940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary calprotectin is elevated in patients with active inflammatory bowel disease.
    Majster M; Almer S; Boström EA
    Arch Oral Biol; 2019 Nov; 107():104528. PubMed ID: 31442931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Oral Microbial Markers for Differential Diagnosis of Crohn's Disease and Ulcerative Colitis Using Machine Learning Models.
    Kang SB; Kim H; Kim S; Kim J; Park SK; Lee CW; Kim KO; Seo GS; Kim MS; Cha JM; Koo JS; Park DI
    Microorganisms; 2023 Jun; 11(7):. PubMed ID: 37512838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
    PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of selected neutrophil protein plasma concentrations in the diagnosis of Crohn's disease and ulcerative colitis - a preliminary report.
    Pawlica-Gosiewska D; Solnica B; Gawlik K; Cibor D; Mach T; Fedak D; Owczarek D
    Postepy Hig Med Dosw (Online); 2017 Apr; 71(0):243-253. PubMed ID: 28397705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment regimens and disease activity could alter salivary myeloperoxidase levels in patients with inflammatory bowel diseases.
    Nijakowski K; Motylewska B; Banasik E; Rutkowski R; Tsaryk V; Łuczak J; Korybalska K; Witowski J; Surdacka A; Eder P
    Pol Arch Intern Med; 2024 Jan; 134(1):. PubMed ID: 38164522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
    Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
    World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
    Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
    World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metaproteomics of fecal samples of Crohn's disease and Ulcerative Colitis.
    Lehmann T; Schallert K; Vilchez-Vargas R; Benndorf D; Püttker S; Sydor S; Schulz C; Bechmann L; Canbay A; Heidrich B; Reichl U; Link A; Heyer R
    J Proteomics; 2019 Jun; 201():93-103. PubMed ID: 31009805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary Stress/Immunological Markers in Crohn's Disease and Ulcerative Colitis.
    Finamore A; Peluso I; Cauli O
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis.
    Bridger S; Lee JC; Bjarnason I; Jones JE; Macpherson AJ
    Gut; 2002 Jul; 51(1):21-5. PubMed ID: 12077086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crohn's-like clinical and pathological manifestations of giant inflammatory polyposis in IBD: a potential diagnostic pitfall.
    Naymagon S; Mikulasovich M; Gui X; Ullman TA; Harpaz N
    J Crohns Colitis; 2014 Jul; 8(7):635-40. PubMed ID: 24368253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PR3-ANCA and panel diagnostics in pediatric inflammatory bowel disease to distinguish ulcerative colitis from Crohn's disease.
    Horn MP; Peter AM; Righini Grunder F; Leichtle AB; Spalinger J; Schibli S; Sokollik C
    PLoS One; 2018; 13(12):e0208974. PubMed ID: 30557305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.